OpenURL Connection Search

Select item for more details and to access through your institution.

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14586, doi. 10.3390/ijms232314586
By:
- Lara, Joshua J.;
- Bencomo-Alvarez, Alfonso E.;
- Gonzalez, Mayra A.;
- Olivas, Idaly M.;
- Young, James E.;
- Lopez, Jose L.;
- Velazquez, Vanessa V.;
- Glovier, Steven;
- Keivan, Mehrshad;
- Rubio, Andres J.;
- Dang, Sara K.;
- Solecki, Jonathan P.;
- Allen, Jesse C.;
- Tapia, Desiree N.;
- Tychhon, Boranai;
- Astudillo, Gonzalo E.;
- Jordan, Connor;
- Chandrashekar, Darshan S.;
- Eiring, Anna M.
Publication type:
Article
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Published in:
Clinical & Translational Medicine, 2022, v. 12, n. 12, p. 1, doi. 10.1002/ctm2.1146
By:
- Gonzalez, Mayra A.;
- Olivas, Idaly M.;
- Bencomo‐Alvarez, Alfonso E.;
- Rubio, Andres J.;
- Barreto‐Vargas, Christian;
- Lopez, Jose L.;
- Dang, Sara K.;
- Solecki, Jonathan P.;
- McCall, Emily;
- Astudillo, Gonzalo;
- Velazquez, Vanessa V.;
- Schenkel, Katherine;
- Reffell, Kelaiah;
- Perkins, Mariah;
- Nguyen, Nhu;
- Apaflo, Jehu N.;
- Alvidrez, Efren;
- Young, James E.;
- Lara, Joshua J.;
- Yan, Dongqing
Publication type:
Article
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Published in:
Cells (2073-4409), 2021, v. 10, n. 9, p. 2390, doi. 10.3390/cells10092390
By:
- Rubio, Andres J.;
- Bencomo-Alvarez, Alfonso E.;
- Young, James E.;
- Velazquez, Vanessa V.;
- Lara, Joshua J.;
- Gonzalez, Mayra A.;
- Eiring, Anna M.
Publication type:
Article
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study.
Published in:
Cancer (0008543X), 2021, v. 127, n. 7, p. 1068, doi. 10.1002/cncr.33347
By:
- Bencomo‐Alvarez, Alfonso E.;
- Gonzalez, Mayra A.;
- Rubio, Andres J.;
- Olivas, Idaly M.;
- Lara, Joshua J.;
- Padilla, Osvaldo;
- Orazi, Attilio;
- Corral, Javier;
- Philipovskiy, Alexander;
- Gaur, Sumit;
- Mulla, Zuber D.;
- Dwivedi, Alok K.;
- Eiring, Anna M.
Publication type:
Article

Found: 4

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.

Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study.